Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Author Correction: Recombinant collagen polypeptide as a versatile bone graft biomaterial

The Original Article was published on 20 November 2020

Correction to: Communications Materials, published online 20 November 2020.

The original version of this Article incorrectly labelled regions of interest in Fig. 5i. This has now been corrected in HTML and PDF versions of the Article.

Author information



Corresponding author

Correspondence to Hideo Fushimi.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fushimi, H., Hiratsuka, T., Okamura, A. et al. Author Correction: Recombinant collagen polypeptide as a versatile bone graft biomaterial. Commun Mater 1, 102 (2020).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing